Lannett Co Inc News Headlines

LCI 
$56.7
*  
0.81
1.45%
Get LCI Alerts
*Delayed - data as of Oct. 31, 2014  -  Find a broker to begin trading LCI now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    LCI After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Pacira Down on Wider than Expected Q3 Loss, Sales Miss - Analyst Blog
10/31/2014 1:00:00 PM - Zacks.com


Strength Seen in Cempra (CEMP): Stock Rises 10.1% - Tale of the Tape
10/31/2014 9:25:00 AM - Zacks.com


A Small-Cap Buy That's Not So Spooky
10/29/2014 2:09:00 PM - Seeking Alpha


United Therapeutics Falls on Q3 Loss, Revenues Miss - Analyst Blog
10/29/2014 12:02:00 PM - Zacks.com


Receptos (RCPT) Worth Watching: Stock Moves Up 41.4% - Tale of the Tape
10/29/2014 9:39:00 AM - Zacks.com


Regulus Therapeutics (RGLS) Soars: Stock Rises 6.6% - Tale of the Tape
10/28/2014 8:51:00 AM - Zacks.com


Lannett Co. Gets Growth Rx In Generic Drugs Group
10/27/2014 5:59:00 PM - Investor's Business Daily


Will Kforce (KFRC) Q3 Earnings Surprise this Season? - Analyst Blog
10/24/2014 1:45:00 PM - Zacks.com


Why Lannett (LCI) Stock Is Surging Today
10/23/2014 3:24:00 PM - TheStreet


Lannett Sees Q1 Results Above View
10/23/2014 10:12:00 AM - RTT News


Pharmacyclics Up on Label Expansion Efforts for Imbruvica - Analyst Blog
10/22/2014 1:54:00 PM - Zacks.com


Abbott Labs' (ABT) Earnings Up Y/Y in Q3, Guidance Updated - Analyst Blog
10/22/2014 10:28:00 AM - Zacks.com


AbbVie Drops Shire Deal, Announces Buyback, Ups Dividend - Analyst Blog
10/21/2014 4:32:00 PM - Zacks.com


ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape
10/21/2014 8:44:00 AM - Zacks.com


Is Lannett Company (LCI) a Great Growth Stock? - Tale of the Tape
10/21/2014 8:38:00 AM - Zacks.com


PEG Ratio vs. the P/E Ratio - Screen of the Week
10/21/2014 4:14:00 AM - Zacks.com


Tetraphase (TTPH) in Focus: Stock Gains 19.9% - Tale of the Tape
10/20/2014 9:46:00 AM - Zacks.com


Astellas Files for Amendment of Isavuconazole Study Protocol - Analyst Blog
10/17/2014 5:15:00 PM - Zacks.com


Aquinox Pharmaceuticals (AQXP) Jumps: Stock Soars 22.4% - Tale of the Tape
10/17/2014 9:27:00 AM - Zacks.com


Novartis Presents Encouraging Data on Leukemia Candidate - Analyst Blog
10/16/2014 6:40:00 PM - Zacks.com


Shire (SHPG) Shares Crash on Concerns Over AbbVie Buyout - Analyst Blog
10/16/2014 12:47:00 PM - Zacks.com


BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 14.7% - Tale of the Tape
10/16/2014 9:25:00 AM - Zacks.com


Sucampo/Takeda Amend Collaboration Agreement for Amitiza - Analyst Blog
10/15/2014 6:07:00 PM - Zacks.com


Pacira (PCRX) Reveals Additional Safety Data on Exparel - Analyst Blog
10/14/2014 5:45:00 PM - Zacks.com


Sucampo Enters into Settlement Agreement for Amitiza - Analyst Blog
10/13/2014 5:50:00 PM - Zacks.com